Arrhythmias in Dogs and Cats: When the Heart Loses Its Rhythm

The heart is not simply a muscular pump — it is an extraordinarily sophisticated electromechanical organ that relies on a precisely coordinated electrical conduction system to maintain the rhythmic contractions that sustain life. Every heartbeat originates as an electrical impulse in the sinoatrial (SA) node, a small cluster of specialised pacemaker cells located in the right atrium. These cells spontaneously generate electrical impulses at a regular rate — typically 60 to 140 beats per minute in dogs (varying significantly by breed and size) and 140 to 220 beats per minute in cats. The impulse spreads across both atria, causing them to contract and push blood into the ventricles, then reaches the atrioventricular (AV) node, which introduces a brief, precisely timed delay before conducting the signal to the ventricles through the bundle of His and Purkinje fibres. This coordinated sequence ensures that the atria and ventricles contract in proper sequence, maximising the efficiency of blood pumping.

"An arrhythmia is not a disease in itself — it is a sign that something is affecting the heart's electrical system. The critical question is always whether the arrhythmia is benign and incidental, or whether it is haemodynamically significant — meaning it is compromising the heart's ability to pump blood effectively. This distinction determines whether treatment is needed and how urgently we must intervene." — Dr. Sarah Chen, DVM

When any component of this conduction system malfunctions — whether the SA node fires too quickly, too slowly, or erratically; the AV node conducts too rapidly, too slowly, or not at all; or abnormal electrical foci in the atria or ventricles generate competing impulses — the result is an arrhythmia: an abnormal heart rhythm. Arrhythmias range from completely benign (such as sinus arrhythmia in dogs, which is a normal variation linked to breathing) to immediately life-threatening (such as ventricular fibrillation, in which the ventricles quiver chaotically instead of contracting effectively, producing no meaningful blood flow). Between these extremes lies a spectrum of arrhythmias that require careful evaluation to determine their significance and the need for treatment.

Understanding arrhythmias requires recognising that they can arise from virtually any heart disease, as well as from numerous non-cardiac conditions. Structural heart diseases such as dilated cardiomyopathy and hypertrophic cardiomyopathy frequently cause arrhythmias by altering the heart's anatomy and disrupting normal conduction pathways. But arrhythmias can also result from electrolyte imbalances, toxin exposure, severe systemic illness, autonomic nervous system dysfunction, and even certain medications — making a thorough diagnostic workup essential for every patient with an abnormal rhythm.

Cardiac arrhythmias are broadly classified based on their origin (supraventricular or ventricular), their effect on heart rate (tachycardia, bradycardia, or normal rate), and their clinical significance. Understanding the major categories helps owners grasp why their veterinarian may be concerned about one type of arrhythmia but not another.

Supraventricular arrhythmias originate above the ventricles — in the atria or the AV node. Atrial fibrillation (AF) is the most clinically significant supraventricular arrhythmia in dogs and is characterised by rapid, chaotic electrical activity in the atria that replaces the normal organised atrial contraction. The atria effectively quiver rather than contract, and the AV node is bombarded with hundreds of impulses per minute, conducting a variable number to the ventricles and producing an irregularly irregular heart rhythm. In dogs, AF is most commonly seen in giant and large breeds with dilated cardiomyopathy or advanced mitral valve disease, but it can also occur as 'lone atrial fibrillation' in giant breeds (Great Danes, Irish Wolfhounds, Newfoundlands) without obvious underlying structural disease. Supraventricular tachycardia (SVT) produces a regular but abnormally rapid heart rate driven by an abnormal electrical circuit or focus above the ventricles. While less common than AF, SVT can cause significant haemodynamic compromise when sustained, leading to weakness, exercise intolerance, and even heart failure.

Ventricular arrhythmias originate within the ventricles themselves and are generally considered more dangerous than supraventricular arrhythmias because they can more readily degenerate into ventricular fibrillation and sudden cardiac death. Ventricular premature complexes (VPCs) are the most common ventricular arrhythmia, representing premature beats generated by an abnormal electrical focus within the ventricular muscle. Occasional isolated VPCs may be clinically insignificant, but frequent VPCs (more than 20 to 30 per minute), multiform VPCs (arising from multiple abnormal foci), pairs (couplets), and runs of three or more consecutive VPCs (ventricular tachycardia) are progressively more concerning. Ventricular tachycardia (VT) — sustained runs of rapid ventricular beats at rates exceeding 150 to 200 per minute — is a potentially life-threatening arrhythmia that can compromise cardiac output and degenerate into ventricular fibrillation. Boxer cardiomyopathy (arrhythmogenic right ventricular cardiomyopathy or ARVC) is a well-known breed-specific condition that predisposes affected Boxers to ventricular arrhythmias and sudden death.

Bradyarrhythmias — abnormally slow heart rhythms — include sick sinus syndrome (SSS), in which the SA node fails to generate impulses at an adequate rate, and atrioventricular block, in which the conduction of impulses from atria to ventricles is delayed (first-degree block), intermittently blocked (second-degree block), or completely interrupted (third-degree or complete heart block). SSS is most commonly seen in Miniature Schnauzers, West Highland White Terriers, and Cocker Spaniels. Complete heart block results in a very slow ventricular rate (often 30 to 50 beats per minute in dogs) driven by an escape pacemaker in the ventricles, which may be insufficient to maintain adequate blood flow during activity, causing exercise intolerance, weakness, and syncope (fainting episodes).

Arrhythmias can arise from a wide array of cardiac and non-cardiac causes, and identifying the underlying trigger is essential for determining appropriate management. In many cases, treating the underlying cause resolves the arrhythmia without the need for specific antiarrhythmic therapy.

Primary cardiac causes are the most common origin of clinically significant arrhythmias in both dogs and cats. Dilated cardiomyopathy (DCM) is strongly associated with both atrial fibrillation and ventricular arrhythmias — the progressive stretching and fibrosis of the heart muscle disrupts normal electrical conduction pathways and creates conditions favourable for abnormal electrical circuits. Hypertrophic cardiomyopathy (HCM) in cats predisposes to atrial arrhythmias (particularly atrial fibrillation and atrial premature complexes) due to left atrial enlargement, and may also cause ventricular arrhythmias from the disorganised myocardial fibre architecture characteristic of the disease. Chronic valvular disease (myxomatous mitral valve disease), the most common acquired heart condition in small breed dogs, can lead to atrial fibrillation when the left atrium becomes severely enlarged. Congenital heart defects may also predispose to arrhythmias through abnormal cardiac anatomy. Dogs with heart murmurs should be evaluated for underlying conditions that may also cause arrhythmias.

Non-cardiac causes of arrhythmias are frequently overlooked but clinically important. Electrolyte imbalances — particularly hypokalaemia (low potassium), hyperkalaemia (high potassium), hypocalcaemia, and hypomagnesaemia — can profoundly affect the heart's electrical properties and trigger dangerous arrhythmias. Hyperkalaemia, commonly seen in dogs with Addison's disease (hypoadrenocorticism) or urinary obstruction, is especially dangerous, causing progressive bradycardia and conduction disturbances that can lead to cardiac arrest if not corrected urgently. Gastric dilatation-volvulus (GDV or bloat) in dogs frequently causes ventricular arrhythmias due to a combination of myocardial ischaemia (reduced blood flow to the heart muscle), electrolyte disturbances, and the release of myocardial depressant factors — ventricular arrhythmias may develop during or up to 72 hours after surgical correction of the GDV. Splenic disease, particularly haemangiosarcoma and splenic torsion, is strongly associated with ventricular arrhythmias in dogs.

Other non-cardiac triggers include severe systemic illness (sepsis, pancreatitis, trauma), toxin exposure (chocolate/theobromine toxicity, digitalis toxicity, certain rodenticides), anaemia (the heart compensates for reduced oxygen-carrying capacity by increasing rate, predisposing to tachyarrhythmias), hyperthyroidism in cats (which causes sinus tachycardia and predisposes to atrial arrhythmias), and hypothyroidism in dogs (which can cause sinus bradycardia). Certain medications — including some anaesthetic agents, bronchodilators, and cardiac glycosides — can also be proarrhythmic. If your pet shows signs of distress or pain alongside irregular heartbeat, seek veterinary evaluation promptly.

Accurate diagnosis and characterisation of arrhythmias requires specialised cardiac diagnostics. While a veterinarian may suspect an arrhythmia during routine physical examination by detecting an irregular pulse or abnormal heart sounds with a stethoscope, definitive identification of the specific arrhythmia type requires recording the heart's electrical activity.

Electrocardiography (ECG) is the gold standard for diagnosing arrhythmias. An ECG records the electrical activity of the heart through electrodes placed on the skin, producing a tracing that displays the timing and morphology of each electrical event in the cardiac cycle. The P wave represents atrial depolarisation, the QRS complex represents ventricular depolarisation, and the T wave represents ventricular repolarisation. By analysing the rate, rhythm, and morphology of these waveforms, the veterinary cardiologist or experienced general practitioner can identify the specific type of arrhythmia, determine its origin (supraventricular vs ventricular), and assess its severity. A standard six-lead ECG provides a snapshot of the heart's electrical activity over a few minutes, which is often sufficient for diagnosing sustained arrhythmias such as atrial fibrillation or persistent ventricular tachycardia.

Holter monitoring is an invaluable diagnostic tool for arrhythmias that are intermittent or paroxysmal — meaning they come and go unpredictably and may not be present during a brief in-clinic ECG recording. A Holter monitor is a portable ECG device that the pet wears (usually secured in a vest or wrap) for 24 to 48 hours while going about normal daily activities at home. The continuous recording captures every heartbeat over the monitoring period, revealing intermittent arrhythmias that might be missed on a standard ECG. Holter monitoring is particularly important for evaluating breeds predisposed to arrhythmogenic conditions — for example, screening Boxers for ARVC, Doberman Pinschers for occult DCM, and Cavalier King Charles Spaniels for the combination of mitral valve disease and arrhythmias. It is also used to monitor the effectiveness of antiarrhythmic drug therapy, guiding dose adjustments based on objective data rather than single-point-in-time assessments.

Echocardiography (cardiac ultrasound) does not directly diagnose arrhythmias but is an essential complementary test that evaluates the structural and functional status of the heart. Echocardiography reveals whether an arrhythmia is occurring in the context of underlying structural heart disease — such as chamber enlargement, wall thickening, valvular abnormalities, or reduced contractility — which profoundly influences treatment decisions and prognosis. A dog with occasional VPCs and a structurally normal heart on echocardiography has a vastly different prognosis than a dog with the same arrhythmia in the context of dilated cardiomyopathy with severe systolic dysfunction. Additional diagnostics may include blood pressure measurement (hypertension can exacerbate arrhythmias), complete blood work (to identify electrolyte imbalances, thyroid disease, or other metabolic triggers), and thoracic radiographs (to assess heart size and screen for pulmonary oedema or other signs of heart failure).

The decision to treat an arrhythmia — and how aggressively to treat it — depends on the type of arrhythmia, its haemodynamic impact, the underlying cause, and the risk of progression to more dangerous rhythms. Not all arrhythmias require specific antiarrhythmic therapy; some are benign, some resolve when the underlying cause is treated, and others require careful risk-benefit analysis before committing to long-term medication.

Antiarrhythmic drug therapy is the primary treatment modality for clinically significant tachyarrhythmias. For supraventricular tachycardias including atrial fibrillation, rate control is typically the therapeutic goal — drugs such as diltiazem (a calcium channel blocker) and digoxin (a cardiac glycoside) slow conduction through the AV node, reducing the ventricular response rate to a more physiologically appropriate range. In dogs with lone atrial fibrillation or recent-onset AF, cardioversion (restoration of normal sinus rhythm) may be attempted using intravenous antiarrhythmic drugs or electrical cardioversion, although recurrence rates are high and long-term rate control is usually required regardless. For ventricular arrhythmias, the drug selection depends on the specific clinical scenario. Lidocaine administered intravenously is the first-line acute treatment for life-threatening sustained ventricular tachycardia. For chronic oral management of ventricular arrhythmias, sotalol (a combined beta-blocker and class III antiarrhythmic) and mexiletine are commonly prescribed, often in combination for synergistic effect — this combination is widely used in Boxers with ARVC and Doberman Pinschers with DCM-associated ventricular arrhythmias.

Permanent pacemaker implantation is the definitive treatment for symptomatic bradyarrhythmias — primarily sick sinus syndrome and complete (third-degree) atrioventricular block — that do not respond to medical management and are causing clinical signs such as syncope, exercise intolerance, or heart failure. The procedure involves implanting a pulse generator (battery and electronics) subcutaneously or submuscularly, with a transvenous lead threaded through a jugular vein into the right ventricle (or, in dual-chamber systems, the right atrium and right ventricle). Pacemaker implantation in dogs is a well-established procedure performed at veterinary referral hospitals and universities, with excellent success rates and significant improvement in quality of life. Most pacemaker generators last six to ten years, and many dogs live normal or near-normal lifespans following implantation.

Monitoring and follow-up are essential components of arrhythmia management. Dogs on antiarrhythmic medication require regular Holter monitoring (typically every three to six months) to assess treatment efficacy, detect breakthrough arrhythmias, and guide dose adjustments. Blood levels of certain drugs (particularly digoxin, which has a narrow therapeutic index) must be monitored to avoid toxicity. Dogs with pacemakers require periodic interrogation of the device to check battery status, lead function, and programming. Owners should be educated about signs of heart failure and sudden deterioration — such as collapse, severe weakness, rapid breathing, or prolonged fainting episodes — that warrant emergency veterinary attention, as arrhythmias can progress unpredictably despite therapy.

Receiving a diagnosis of cardiac arrhythmia in a beloved pet can be frightening, but it is important to understand that the prognosis varies enormously depending on the specific type of arrhythmia, the presence or absence of underlying structural heart disease, and the response to treatment. Many pets with arrhythmias live comfortable, active lives for years with appropriate management.

Benign arrhythmias — such as sinus arrhythmia in dogs (a normal, respiratory-linked rhythm variation), occasional isolated supraventricular premature complexes, and rare, isolated VPCs in an otherwise healthy heart — require no treatment and do not affect lifespan or quality of life. These are often incidental findings during routine examination or pre-anaesthetic screening and, once documented and characterised, simply need periodic monitoring to ensure they remain stable.

Managed arrhythmias — such as atrial fibrillation with adequate rate control, ventricular arrhythmias suppressed by antiarrhythmic medication, and bradyarrhythmias corrected by pacemaker implantation — allow many pets to enjoy a good quality of life, though they may require some modifications. Exercise tolerance may be reduced compared to before the arrhythmia developed, and owners may need to moderate their pet's activity levels accordingly. Regular veterinary visits for monitoring and medication adjustments become part of the routine. Medications must be given consistently and on schedule, and owners should be alert to potential side effects — lethargy, gastrointestinal upset, or worsening clinical signs may indicate the need for dose adjustment or drug change.

The prognosis is more guarded when arrhythmias occur in the context of progressive underlying heart disease. A Doberman Pinscher with ventricular arrhythmias secondary to dilated cardiomyopathy faces a more serious prognosis than a dog with idiopathic ventricular arrhythmias in a structurally normal heart — not because of the arrhythmia itself, but because the underlying cardiomyopathy continues to progress. Similarly, a cat with atrial arrhythmias secondary to advanced HCM carries risks related to both the arrhythmia and the underlying disease (including thromboembolism). In these cases, the arrhythmia management is one component of a comprehensive cardiac care plan that addresses the primary disease process. For all pets with cardiac arrhythmias, maintaining overall health through appropriate senior care and breed-appropriate exercise supports the best possible outcome.